EP Global Communications Inc fka EPGL

[Valiant]

They released the financial benefits:

Financial Benefit:

CooperVision has secured the exclusive right to co-develop EPGL advanced technologies of its choosing, with ownership of resulting intellectual property to be allocated in accordance with inventorships. EPGL has agreed to work exclusively with CooperVision in the ophthalmic and medical field to develop selected advanced technologies, granting CooperVision exclusive options to license or outright purchase EPGL’s rights to such technologies.

Finanicial Benefit:

Under the Agreement, CooperVision will fund the co-development, prototyping, manufacturing and marketing of such technologies selected by CooperVision and negotiated project by project. This Development Agreement is on-going.

Financial Benefit:

Under the terms of the Development Agreement, revenues from successful development of new products with CooperVision, will result from outright purchase of EPGL technologies and/or on-going share of sales revenues as negotiated between the companies.

No company releases exact details of their financial agreements.